|
|
|
|
|
|
| Advertisement |
 |
|
|
| 2018 EPL Nominations Deadline Approaching! |
|
|
|
|
| Advertisement |
 |
Deloitte's 2018 Life Sciences Accounting & Financial Reporting Update
How can life sciences companies keep pace with emerging accounting and financial reporting challenges? Learn about new accounting standards for revenue recognition, leases, and definition of a business and existing rules for R&D, acquisitions and divestitures, income taxes and more. Our ninth annual report also includes interpretive guidance to help you address these challenges.
 Download now.
|
|
|
|
| PE Top 50 |
 |
|
Pharm Exec's Top 50 Companies 2018
|
Pharm Exec's annual listing of the top biopharma players shows that most are holding their ground as they weigh a more challenging business climate with new opportunities for growth in a potentially resurgent marketplace.
... /Read more/ |
|
|
| Advertisement |
A Framework for Successful Biopharma Launches Understanding the launch archetype and identifying critical success factors
Wednesday, July 11, 2018 at 11am EDT
 Register now
|
|
| Featured |
 |
The Pharm Exec Podcast:
Episode 10
|
In the tenth episode of the Pharm Exec podcast series, Michelle and Christen host one of Pharm Exec's Emerging Pharma Leaders, Sabina Ewing, vice president of business technology for Pfizer, and discuss the difference and importance of mentoring and sponsoring in business and pharma.
... /Read more/ |
|
|
| Advertisement |
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
On Demand
 Learn more
|
|
| Advertisement |
Combination Therapies in Oncology: The Benefits of Integrated Insights
On Demand
 Learn more
|
|
| Market Access |
 |
|
Amryt Pharma: Realizing Rare Disease Treatments |
|
Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma—building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market. .. /Read more/ |
|
|
|
|
|
|
|
|
